PRTN3 and sclerosing cholangitis: In another study, c-ANCA via chemiluminescence assay was also detected in 38.5 % of cases of primary sclerosing cholangitis compared to 10.6 % of liver disease controls, and this elevation was not exclusively related to underlying IBD [11].